OKYO Pharma has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, purchased 50,000 of the Company’s ordinary shares on NASDAQ at a price of US$1.03 per share. This brings the total shareholding of Mr Cerrone to 9,851,570 shares which is 29.12% of issued share capital.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
- OKYO Pharma Chairman Boosts Stake, Advances Trials
- Okyo Pharma announces acquisition of shares by chairman
- OKYO Pharma Secures U.S. Patent for DED Therapy
- Okyo granted U.S. patent covering OK-101’s for DED treatment
- OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease